Drug Shortage Report for MIRAPEX
| Report ID | 4326 |
| Drug Identification Number | 02241594 |
| Brand name | MIRAPEX |
| Common or Proper name | Mirapex |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90 |
| ATC code | N04BC |
| ATC description | DOPAMINERGIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-03-20 |
| Estimated end date | 2017-04-04 |
| Actual end date | 2017-04-05 |
| Shortage status | Resolved |
| Updated date | 2017-04-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-04-06 | French | Compare |
| v3 | 2017-04-06 | English | Compare |
| v2 | 2017-03-25 | French | Compare |
| v1 | 2017-03-25 | English | Compare |
Showing 1 to 4 of 4